Objective: The aim of this article was to evaluate in normal older adults and preclinical Alzheimer's disease (AD) the impact of amyloid and regional tauopathy on cerebral glucose metabolism and subsequent memory decline. Methods: We acquired positron emission tomography using F18 flortaucipir (tau), C11 Pittsburgh compound B (amyloid), and F18 fluorodeoxyglucose (FDG) in 90 clinically normal elderly of the Harvard Aging Brain Study. Results: Posterior cingulate metabolism decreased when both amyloid and neocortical tau were high and predicted subsequent memory decline in a larger sample of normal elderly. In contrast, frontal hypometabolism related to the common age-related entorhinal tauopathy, but this dysfunction was independent of amyloid, and did not predict significant memory decline. Neocortical tauopathy was positively associated with metabolism in individuals with subthreshold amyloid, suggesting that glucose metabolism increases before decreasing in the course of preclinical AD. Interpretation: Our study identified a synergistic effect of amyloid and tau deposits and demonstrated, for the first time, in normal elderly its link to AD-like hypometabolism and to AD-like memory decline. The amyloid effect was observed with tau in neocortex, but not with tau in entorhinal cortex, which is the common site of age-related tauopathy. Entorhinal tau was associated with frontal hypometabolism, but this dysfunction was not associated with memory loss.
A lzheimer's disease (AD) is a neurodegenerative disorder expressed clinically by a progressive memory decline leading to dementia in which brain amyloid-beta (Ab) plaques and tau neurofibrillary tangles slowly accumulate as the cardinal pathologic features. 1, 2 Autopsy studies suggest that tau pathology appears in the medial temporal lobe before the appearance of Ab pathology in neocortex, 3 and that both pathologies appear before cognitive decline, defining a preclinical, asymptomatic stage of AD 3, 4 that may progress to the symptomatic stage, AD dementia. 5 Neural dysfunction and cell death are thought to result from the interaction of the two pathologies, but our ability to assess the linkage between early pathology and dysfunction during life has been quite limited. Furthermore, cognitive symptoms correlate best with autopsy evidence of tau deposition that has expanded from medial temporal lobe to neocortex, 1 but the differential association of medial temporal and neocortical tau depositions with in vivo brain function has not been evaluated. The development of in vivo imaging of tau pathology followed the introduction of the selective tau ligand, 18 F flortaucipir (FTP; also known as AV1451 or T807), used with positron emission tomography (PET). [6] [7] [8] [9] [10] [11] Tau-PET permits for the first time a regional assessment of tau pathology in relation to age, amyloidosis, and brain functional integrity, measured with 18 F fluorodeoxyglucose (FDG-PET). We sought to determine whether the anatomic pattern of association cortex dysfunction typically associated with AD [12] [13] [14] was related to brain amyloidosis and tau deposition detected in clinically normal elderly. Second, we aimed to determine whether Ab-and tau-associated hypometabolism related to subsequent memory decline, using thus Ab-and tau-PET imaging to identify brain regions in which glucose metabolism predicts future memory decline in older adults with normal memory at baseline. Our results indicate that the interaction of AD pathological hallmarks, Ab and neocortical tau, relates to posterior cingulate hypometabolism, which, in turn, predicts memory deterioration.
Patients and Methods

Participants
Participants included in this report were recruited from the Harvard Aging Brain Study (HABS), a longitudinal study of aging and preclinical AD (Table 1) . They were all clinically normal older adults at the time of FTP imaging: Mini-Mental State Examination (MMSE) was !26/30, and Logical Memory II subscale (Delayed Paragraph Recall) was normal for education: !9/25 if education !16 years, !6/25 otherwise. Ninety participants with FTP (tau), Pittsburgh compound B (PiB; Ab), and FDG (glucose metabolism) PET examinations conducted over the same year were included in a first study sample. Two hundred seventy-seven participants with longitudinal memory assessments, Pittsburgh compound B (PiB), and FDG-PET examinations were included in a second sample. All participants underwent a comprehensive medical and neurological evaluation and none had serious medical or neurological conditions, history of alcoholism, drug abuse, or family history of dominant AD. None were clinically depressed when entering the study (Geriatric Depression Scale <11/30) or had other psychiatric illnesses. Participants provided informed consent and were studied under protocols approved by the Partners Human Research Committee at the Massachusetts General Hospital.
Neuropsychological Assessment
We evaluated changes in memory performance using the Free and Cued Selective Reminding Test (FCSRT). 15 The FCSRT is a 16-item verbal memory test, selectively reminding items that Age and cognitive data are given at the closest time of 18 F FTP imaging in sample 1 and at baseline in sample 2. Significant differences between low-and high-PiB participants are highlighted: two-sided *p < 0.050; **p < 0.010. have been forgotten over three successive trials. In the encoding phase, each item is presented with a semantic cue. Every four items, an immediate cued recall controls that encoding has been adequately performed. In the delayed recall phase, participants are first asked to freely recall as many items as possible; next, categorical cueing is provided for those items that were not spontaneously retrieved. We used the total free recall (/48) and the total cued recall (/48) performance over the three trials. HABS participants undergo annual cognitive testing, including the FCSRT. All together, the 277 HABS participants included in this study had 1,230 FCSRT evaluations, on average: 4.4 6 1.2 per participant (minimum,2; maximum, 6 evaluations).
The average follow-up duration was 3.6 6 1.3 years (minimum, 0.9; maximum, 5.6).
Brain Imaging Procedures
Magnetic resonance imaging (MRI) was performed on a Siemens 3 Tesla Tim Trio (Siemens, Erlangen, Germany) and included a three-dimensional (3D) structural T 1 -weighted scan using a repetition time 50.9) . PET data were acquired on a Siemens ECAT HR1 scanner using a 3D mode; 63 image planes; 15.2-cm axial field of view; 5.6-mm transaxial resolution; and 2.4-mm slice interval. T807 was acquired from 80 to 100 minutes (min) after a 9.0-to 11.0-millicurie (mCi) bolus injection in 4 3 5-min frames. FDG was acquired from 45 to 75 minutes after a 5-to 10-mCi bolus injection in 6 3 5-min frames. PiB was acquired with an 8.5-to 15-mCi bolus injection followed immediately by a 60-minute dynamic acquisition in 69 frames (12 3 15 seconds, 57 3 60 seconds). PET images were coregistered to the corresponding T 1 image for each subject using six degrees of freedom, rigid body registration, and structural ROIs, as determined by Freesurfer, were mapped into native PET space in SPM8. FTP and FDG were expressed as standard uptake volume ratios (SUVRs) and PiB as the distribution volume ratio (DVR) using the Logan graphical method, with slopes extracted from the 40-to 60-minute time frame. All PET data used the cerebellum as the reference region (gray matter only) and were corrected for partial volume effects using MRI-based methods (geometric transfer matrix 16, 17 for ROI and extended M€ uller-G€ artner 17, 18 for surface analyses).
The point spread function for partial volume correction was estimated at 6mm. PiB retention was assessed using a large neocortical aggregate that included superior frontal, rostral middle frontal, rostral anterior cingulate, medial orbitofrontal, inferior and middle temporal, inferior parietal, and precuneus (Freesurfer-defined FLR region). Specific analyses were conducted in low-and high-PiB groups: A Gaussian mixture model defined the threshold for PiB positivity (DVR 5 1.34) using the baseline PiB PET scans obtained from the 277 HABS participants, as previously described. 19 FDG and FTP retention were assessed using vertex-wise surface mapping of the cortical ribbon (gray matter threshold: 0.25; smoothing kernel: 10mm) and using Freesurfer-defined ROIs.
Statistical Analyses
Mean and t-statistics maps were computed using the GLM Flex tools (mrtool.mgh.harvard.edu) implemented in Matlab 8.4 (R2014b; The MathWorks, Inc., Natick, MA). Threshold was selected by applying a correction for multiple comparisons using the false discovery rate (FDR; q < 0Á050) in the local correlation map between tracers (Fig 1B, left) . This correction was obtained for a T 5 2.65, p < 0.010 and used for all subsequent analyses. For ROI analyses, Lilliefors tests confirmed that FDG data were close to normal distribution (K < 0.069 for each FDG ROI, p > 0.360; criterion for 90 subjects: 0.094).
We therefore used linear regressions to assess the correlations between FTP and FDG ROIs, with and without adjusting for covariates. We used linear mixed models with a random intercept per subject to relate FDG ROI data to changes in memory.
Results
Temporal Tau Deposition Is Associated With Local FDG Hypometabolism
We first asked whether tau deposits were associated with locally altered glucose metabolism. We computed a mean FTP and a mean FDG map, averaging SUVR values in each vertex across all participants of sample 1. In widespread portions of the temporal and inferior frontal lobes, the average FTP signal was high whereas the average FDG signal was low ( Fig 1A) . In contrast, in the primary cortices, the average FTP signal was low and the average FDG signal high. Temporal Neocortical Tau Is Associated With Distant, Ab-Dependent, FDG Hypometabolism We then asked whether tau deposition in specific regions, where tau was locally associated with hypometabolism, also related to altered metabolism in distant cortical regions. We extracted the FTP signal from two bilateral ROIs: entorhinal and inferior temporal, defined anatomically using Freesurfer, and regressed the FTP signal from these ROIs into the vertex-wise FDG data, adjusting for age. We found that, in addition to the local association, entorhinal FTP was associated with hypometabolism in nearby temporal regions and in inferior frontal, insular, and cingulate gyri (Fig 2A, left: peak p 5 2*e-6, t 5 -5.1). In contrast, FTP binding in the inferior temporal neocortex was not associated with hypometabolism, except in very small nearby areas (Fig 2A, right: peak p 5 2*e-4; t 5 -3.9). When correlating global PiB binding to vertex-wise FDG, virtually no effects were observed (peak p > 0.001). Thus, neither inferior temporal (ie, neocortical) tau nor Ab had major metabolic impact in our sample of normal older adults. We hypothesized that the observed absence of an effect of either neocortical tau or Ab on glucose metabolism might be attributed to differential tau relationships between those with high-and low-Ab burden. We assessed the joint association of global Ab burden and regional tau and found a highly significant interaction between global PiB and inferior temporal FTP predicting FDG metabolism in the bilateral posterior cingulate areas, unilaterally in right anterior temporal and, to a lesser extent, in other temporoparietal areas (Fig 2B, right: peak p 5 e-5; t 5 -4.6). High-PiB participants had hypometabolism (Fig 2C, right: peak p 5 9*e-5; t 5 -4Á5) whereas, in contrast, low-PiB participants had increased metabolism associated with higher levels of inferior temporal tau ( In summary, surface analyses indicated that hypometabolism associated with entorhinal tau was not driven by Ab burden and did not match the regional anatomy typically associated with AD, whereas FDG associated with inferior temporal tau was driven by Ab and primarily involved the temporal and parietal lobes, in a set of regions where metabolism is associated with AD, defined clinically 14 or pathologically. 20 ROI ANALYSES. We aimed to confirm and further control our vertex-wise findings using FDG ROIs to assess the effects of covariates on the association between tau and metabolism: age, sex, education, Ab, and apolipoprotein E (APOE) e4 status. We investigated the associations between entorhinal and inferior temporal FTP and four bilateral Freesurfer-defined FDG ROIs. Entorhinal and inferior temporal FDG ROIs were selected to assess the local association with the corresponding FTP ROIs. We also selected the regions that included the maximal association with entorhinal or inferior temporal FTP in the vertex-wise maps: inferior frontal and posterior cingulate, respectively, labeled "pars triangularis" and "isthmus cingulate" in Freesurfer. ROI results are summarized in Table 2 and illustrated in Figure 4 . We first predicted FDG signal in ROIs with PiB or FTP ROIs without adjusting for any covariate ( Table 2 , box 1): PiB did not significantly predict FDG-PET signal in any ROI. Entorhinal FTP, in contrast, was significantly associated with low metabolism in all FDG ROIs. Inferior temporal FTP was only associated with hypometabolism locally, in the inferior temporal, and in the nearby entorhinal cortex.
We next introduced age, sex, education, PiB, and e4 status as covariates in the FTP-FDG models (box 2): The associations between entorhinal FTP and FDG ROIs remained close to significance after all adjustments, but inferior temporal FTP did not relate to any FDG ROI. To assess the relative strength of these associations, we conducted backward selection models for each FDG ROI with FTP ROIs, PiB, and covariates as predictors. Entorhinal FTP consistently remained in the models whereas inferior temporal FTP and PiB were excluded.
Prediction of signal in FDG ROIs by the interaction between PiB status and FTP ROIs confirmed our vertex-wise findings (box 3A): An interaction between PiB status and inferior temporal FTP, but not entorhinal FTP, was associated with hypometabolism in the posterior cingulate (Fig 4, right) . Results were driven by significant hypometabolism in the high-PiB participants and by a positive association of marginal significance (Table 2 , box 3B; p 5 0.121) in the low-PiB participants.
This latter result suggested the hypothesis that neocortical tau deposition may be associated with increased metabolism at Ab levels below our PiB-PET threshold. To further explore this possibility, we evaluated in the low-PiB participants the association between FDG and the interaction between a continuous PiB measure and inferior temporal FTP. We observed that posterior cingulate FDG increased with the PiB by FTP interaction, demonstrating that the positive FTP-FDG association was driven by individuals with subthreshold levels of PiB binding. In contrast, in the high-PiB subset, the PiB by FTP interaction related to decreased posterior cingulate FDG, confirming that among high-Ab individuals, FDG decreases with increasing levels of tau and Ab burden (box 3C).
To test whether the aforementioned impact of PiB status on the FTP-FDG associations was driven by APOE e4 status, we verified that the associations between FTP and FDG were not different according to e4 status (box 4). We also tested these interactions between e4 and FTP in the low-and high-PiB participants separately, to investigate whether e4 status played a role in the positive and negative associations observed between inferior temporal FTP and posterior cingulate FDG. In the low-PiB participants, the positive FTP-FDG association was stronger in the e4 carriers than in the noncarriers (ageadjusted estimate for the e4 by FTP interaction term: 11.68 6 0.63; p 5 0.010; n 5 8 carriers), although the low-PiB e4 carriers were a small group. In contrast, in the high-PiB participants, the negative FTP-FDG association was not different according to e4 status (estimate: -0.06 6 0.26; p 5 0.825; n 5 19 carriers). In summary, ROI analyses confirmed that the interaction (ie, the multiplicative association) of inferior temporal tauopathy and Ab burden specifically correlates with temporoparietal hypometabolism. When Ab is high, inferior temporal tau is associated with hypometabolism, and the association tends to be more pronounced with increasing levels of Ab, regardless of e4 status. When Ab is low, inferior temporal tau is positively associated with glucose metabolism, specifically in those individuals with subthreshold levels of Ab or carrying an e4 allele. Our findings suggest that tau-associated hypermetabolism may be an earlier sign of brain dysfunction associated with AD pathology than decreased metabolism.
Associations Between FDG Metabolism and Memory Decline
We next tested whether the brain regions in which we identified brain dysfunction associated with tau deposition would also be associated with memory decline. For this purpose, we studied a larger cohort (sample 2, n 5 277) of normal older adults including the previously described participants, but also others who did not have FTP-PET imaging. We analyzed prospective longitudinal memory performances over a mean 4-year period following baseline FDG-PET (1-6 years). We used the four FDG ROIs previously described, hypothesizing that posterior cingulate would best predict future memory decline. Our proxy measure of memory decline was the FCSRT, 15 a highly predictive indicator of progression to AD dementia 21 and of AD pathology in the cerebrospinal fluid (CSF). 22 Demographics of sample 2 participants are given in Table 1 . Memory results are summarized in Table 3 and illustrated in Figure 5 . Posterior cingulate hypometabolism was associated with subsequent decline in both free and cued recall memory, while adjusting for demographics. Adjusting for PiB did not change this result. However, PiB retention strongly interacted with FDG, and when the high and low-PiB subsets were tested separately, posterior cingulate FDG only predicted memory deterioration in the participants with high PiB (Fig 5 right) . Thus, memory decline on a measure highly sensitive to AD was associated with FDG metabolism in the brain area that had the greatest hypometabolism predicted by the tau-Ab interaction.
Because entorhinal cortex is the earliest site of tau deposition and entorhinal tau was linked to inferior frontal hypometabolism, including in the low-Ab participants (Fig 3, left) , we evaluated the association of inferior frontal FDG and memory decline. We found that inferior frontal hypometabolism was associated with a modest decline in free recall that was independent of Ab and marginally significant (estimate: 0. 72 6 0.38; p 5 0.061, adjusting for PiB and demographics). There was no interaction with PiB and no effect on cued recall. The result was similar without PiB in the model (Table 3 ; p 5 0.086).
We finally tested the association of entorhinal FDG and inferior temporal FDG with memory decline because these were the regions where tau deposition had local effects. Interestingly, entorhinal FDG was also associated with subsequent memory decline, specifically in cued recall performance, and PiB interacted with FDG in this region (Fig 5, left) , similar to the finding that tau associates with entorhinal hypometabolism in the high-but not in the low-PiB participants ( Figs 1C and 3) . In contrast, inferior temporal FDG did not relate to memory decline. APOE e4 status did not affect these associations.
Posterior Cingulate FDG Mediates the Effect of Neocortical Tau on Memory in Preclinical AD
Using the 33 high-PiB participants with FTP data, we tested the hypothesis that memory decline is more closely associated with posterior cingulate FDG than with inferior temporal FTP. When both predictors were simultaneously entered in a mixed-model predicting free recall, FDG (estimate: 3.51 6 1.21; p 5 0.004) was associated with decline, but FTP was not (Estimate: -1.11 6 0.92; p 5 0.231). A mediation test formally demonstrated that the tauopathy effect on memory decline was mediated by posterior cingulate hypometabolism (Sobel test: -1.79; p 5 0.037).
Discussion
We acquired PET biomarker measures of the principal pathological deposits of AD, Ab and tau, and related them in normal older persons to FDG PET, a biomarker of glucose metabolism that indicates synaptic activity. We found that the anatomy of glucose hypometabolism, first reported more than 30 years ago in AD, directly correlated with the interaction of both AD pathological hallmarks, Ab and neocortical tau. In patients with symptomatic AD, 23, 24 hypometabolic patterns had been previously observed in relation to Ab and tau measured in the CSF; however, the multiplicative effect was not reported. In addition, associations between CSF tau and FDG metabolism have not been found in normal elderly. 25, 26 The development of tau-PET imaging allowed us to isolate the metabolic signatures of entorhinal and neocortical tauopathy, and to demonstrate that AD-like hypometabolism was specifically associated with neocortical tau. Furthermore, previous studies did not find significant associations between FDG metabolism and memory decline in normal older adults. 27, 28 Using tau-PET to identify FDG ROIs, we demonstrated that FDG metabolism is predictive of memory decline in normal Table 3 individuals with various levels of Ab. More broadly, our finding raises the possibility that AD therapeutic strategies could potentially be successful when either pathology is the target, and that a combination of both strategies and/or therapies targeting the tau-Ab interaction may be most successful.
Neocortical Tau Deposition and Memory Decline Point to the Same FDG Region as AD Vulnerable We found that tau pathology was better correlated with FDG metabolism than Ab, in line with previous neuropathology 29 and CSF 30 studies, but also found that the location of the tau deposition determines the location of tau-related hypometabolism as well as the impact of Ab on metabolic activity. The strongest predictor of cortical hypometabolism was the neocortical tau-Ab interaction, and the anatomy of the predicted hypometabolism included predominantly parietal and temporal lobes ( Fig  2B, right) . These limbic and association cortices have long been noted to undergo progressive deterioration in FDG metabolism along the AD trajectory. 31 Moreover,
we found that the area of greatest hypometabolism, the posterior cingulate, predicted subsequent memory decline, which confirmed that the FDG signal we identified related both to AD pathology and to evidence of progressive amnesia. These findings integrate two anatomically distinct phenomena in AD pathophysiology, temporal lobe tauopathy and parietal physiological change, and relate these processes to progressive memory loss in normal elderly.
Tau-Associated Hypometabolism Is Both Local and Distant and Both Ab Dependent and Ab Independent
To detect signs of a local synaptic toxicity associated with tau deposition, we related FDG and FTP each measured in the same cortical vertex or region. We found local tau effects confined to entorhinal and inferior temporal cortices (Fig 1B, left) , perhaps reflecting the known association at autopsy of tauopathy and local synaptic loss. 4 As elaborated below, these local effects were not evident in low-Ab individuals. We did not observe a local effect of tau in the parietal lobe, 11 possibly because these normal participants did not have sufficient parietal tauopathy for a local effect to be observed. Additional areas of local negative correlation were evident at increasing Ab burdens, which is consistent with hypometabolism reported in high-Ab normal individuals 32 or clinical AD 12 and with recent work that observed spatial concordance between tau and hypometabolism in AD. 33 In contrast, distant associations, that is, those between FDG and FTP-PET signals each measured in different vertices or regions, were observed in widespread neocortical areas. These fell into two categories: those that were consistently attributed to an interaction of tau with Ab and another set of areas that were associated with tau deposition that was independent of Ab (Fig 2) . The key differentiating feature was choice of tau-PET region: When neocortical temporal tau deposition predicted hypometabolism, it was attributed to an interaction with Ab, whereas when entorhinal tau predicted hypometabolism, there was no Ab interaction.
Tau deposition in the temporal neocortex was associated with parietal hypometabolism, most strongly involving posterior cingulate. The association in these areas interacted with Ab, such that FDG only decreased with neocortical tau when Ab was high. This observation is consistent with the view that Ab and tau potentiate the physiological consequences of each other. The mechanism or anatomic connection mediating such an interaction is uncertain; however, a direct disconnection is unlikely to underlie the observed association, because the known connectivity of the inferior temporal gyrus would not predict that the posterior cingulate would be directly affected. A more plausible explanation may simply be that the inferior temporal tau-PET signal is a better tau biomarker because it is amplified among individuals with Ab-related tauopathy, that is, it is a proxy measure of potentially more widespread propagating and Abinteracting tauopathy.
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Positive Associations Between Tau and FDG Metabolism Among the low-Ab participants, FDG metabolism was greater with higher levels of inferior temporal FTP, and this positive association was greater according to Ab level within the low-Ab group. The association was thus driven by subthreshold Ab and was also greater in the small group of low-Ab e4 carriers. Metabolism did not increase with entorhinal tau. These findings raise the possibility that there is an antecedent period of aberrant tau-related hypermetabolism, consistent with data from preclinical autosomal-dominant AD 34 and sporadic AD. 35, 36 Here, we provide evidence that tau-associated AD pathophysiology is underway at Ab levels that are subthreshold using established cutpoints, arguing for an adjustment toward lower cutpoints. Above the Ab threshold, we found tau-associated hypometabolism in regions commonly used as FDG biomarker readouts for AD. Our finding of tau-related increasing metabolism in subjects with subthreshold Ab is consistent with postmortem-PET correlations showing that Ab is evident in a subset of individuals below typical PET thresholds. 37, 38 Whether a putative hypermetabolic phase is a cause or consequence of amyloidosis and/or tauopathy remains uncertain. Tau pathology could be driving increased activity either as compensatory or aberrant activity, or it could be increased activity attributed to incipient amyloidosis. Whereas Ab has also been linked to hypermetabolism, 35, 36 there is also support for the notion of increased neuronal activity fostering tau propagation and hyperphosphorylation. 39 A mechanism related to cognitive reserve could account for higher metabolism in individuals with AD pathology, 40 and early compensatory responses to AD pathologies are possible, highlighting the need for repeated imaging measures beginning in younger individuals. But the present data do suggest that the link to metabolism may be more evidently tau associated than Ab associated.
Ab-Independent Entorhinal Tauopathy Relates to Frontal and Insular Hypometabolism
In contrast to neocortical, entorhinal tauopathy is very commonly observed in this age range at autopsy and is thought to begin before substantial Ab and cognitive impairment. 41, 42 Our entorhinal tau measures did not interact with Ab to predict metabolism. Rather, in those with low-Ab, entorhinal tauopathy was associated most prominently with inferior frontal and insular hypometabolism (Fig 3) . Glucose metabolism in these regions has been associated with aging, 17 and while our data were age adjusted, evaluation of younger individuals will be required. Some entorhinal connectivity to these regions has been reported in rodents 43 ; however, medial temporal ablation in primates was not linked to FDG hypometabolism in these regions, but rather to hippocampal and cingulate hypometabolism. 44 We also observed an Abindependent association between entorhinal tauopathy and cingulate metabolism. Nevertheless, the overall pattern of entorhinal tau-associated hypometabolism was distinct from the typical temporoparietal AD pattern.
Longitudinal PET studies will help determine whether entorhinal tauopathy fosters additional pathology, but without PET detectable amyloidosis, our study suggests that older individuals with entorhinal tauopathy do not manifest the AD-metabolic endophenotype.
Associations Between Glucose Metabolism and Memory Decline
We found that memory progressively declined in individuals with posterior cingulate hypometabolism, the region most strongly linked to the tau-Ab interaction. Previous studies evaluating regional FDG predicted cognitive decline in mild cognitive impairment 45 and in normal subjects reporting subjective impairment. 46 However, in normal elderly, association between FDG and memory decline had not been observed so far. 28 Here, we used a novel tau-Ab interaction assessment to identify a region of FDG hypometabolism and then demonstrated that FDG in this region predicts memory decline in a group of normal elderly with various levels of Ab. Previous work showed that posterior cingulate is critically involved in encoding and retrieval memory processes, 47 likely accounting for the association of metabolism in this region and memory decline. We also found a strong association between memory and entorhinal hypometabolism, similarly driven by the highAb participants. These findings are consistent with the idea that episodic memory specifically decreases with temporolimbic damage. 48, 49 In contrast, the inferior temporal FDG region also identified by the tau-Ab interaction was not associated with memory decline, suggesting that not all hypometabolic regions indicated by the tauAb interaction are associated with memory decline. In addition, we found a modest effect of inferior frontal FDG on free recall decline that was independent of Ab, suggesting that retrieval-based memory inefficiencies prevalent in aging and less specific to AD may be more associated with frontal dysfunction. 50 Our finding that entorhinal tauopathy was strongly associated with inferior frontal hypometabolism, particularly in low-Ab subjects, raises the possibility that medial temporal tauopathy, highly prevalent in this age range, may affect free recall, mediated by frontal dysfunction. Pursuit of this hypothesis will require longer follow-up among those with earlier stages of tau deposition.
